Advanced Neural Prosthetics Research and Development (U01) | Apply Online

Opportunity Summary:

The Advanced Neural Prosthetics Research and Development (U01) opportunity, Funding Opportunity Number PA 09 063, is a National Institutes of Health (NIH) cooperative agreement program aimed at moving neural prosthetics from the lab toward real clinical use. The core intent is translational work and early human testing, with an emphasis on milestone-driven projects that design, develop, and demonstrate neural prosthetic devices that are genuinely clinically useful rather than purely exploratory research tools. In practice, the FOA is trying to fund the critical middle steps that often stall promising neurotechnology: turning prototypes into clinical-grade systems, generating the preclinical evidence needed to justify human studies, and running proof-of-concept or pilot clinical studies to show feasibility and potential benefit.

The FOA supports a fairly broad set of development and translation activities as long as they are tightly connected to producing and testing a neural prosthetic device. Examples of supported work include implementing a clinical prototype device, running preclinical safety and efficacy testing, and conducting design verification and validation activities that demonstrate the device performs as intended and is suitable for clinical use. It also explicitly includes efforts to pursue regulatory approval for a clinical study, which typically means assembling the data package and documentation needed to engage regulators and obtain authorization to begin human testing. On the clinical side, the announcement is oriented toward proof-of-concept and pilot clinical studies, meaning early-stage human investigations intended to establish feasibility, refine the device and procedures, and gather preliminary outcome signals rather than definitive large-scale efficacy trials.

The funding mechanism is a U01 Research Project Cooperative Agreement, which matters because it generally implies closer NIH program involvement than a standard investigator-initiated research grant. In a cooperative agreement structure, projects are expected to be managed against clear, measurable milestones, and NIH staff typically take a more active role in oversight, coordination, and progress assessment. This FOA is also described as running in parallel with PA 09 064, a separate opportunity with the same scientific scope that targets SBIR applicants using the U44 cooperative agreement mechanism (fast-track or Phase II). In other words, this U01 track is intended for eligible academic, nonprofit, government, and certain for-profit applicants, while a companion pathway exists for small business-led development.

Award size and the number of awards are not fixed because NIH anticipates that proposed projects will vary widely in complexity, cost, and time. Applicants may request project periods of up to five years, and the annual direct cost cap is set at 1,000,000 dollars per year for any single year. The FOA notes that actual budgets should be driven by project requirements, but they must stay within that maximum. The listing also indicates an estimated total funding figure of 1,000,000 dollars, though the announcement language makes clear that the final number of awards and total dollars depend on application volume, quality, duration, and requested costs.

Application preparation has a defined length constraint: the Research Plan components are limited to 25 pages for sections 2 through 5 of the PHS 398 format. That limit pushes applicants to be specific and disciplined, especially since milestone-driven cooperative agreements usually require clear technical plans, decision points, and go/no-go criteria.

Eligibility is broad and includes many organization types: public and private institutions of higher education, nonprofits (including 501(c)(3) and certain non-501(c)(3) organizations), for-profit organizations other than small businesses, small businesses, and multiple levels of government (state, county, city/township, special districts), as well as tribal governments and tribal organizations. The eligibility list also explicitly includes entities such as HBCUs, Hispanic-serving institutions, tribally controlled colleges and universities, Alaska Native and Native Hawaiian-serving institutions, faith-based or community-based organizations, U.S. territories or possessions, regional organizations, and even non-U.S. (foreign) entities. The FOA invites any qualified Project Director/Principal Investigator with the necessary skills and resources to apply through their organization, and it reiterates NIH’s standing encouragement for individuals from underrepresented racial and ethnic groups and individuals with disabilities to serve as PDs/PIs.

The announcement allows flexibility in team structure and submission strategy. Multiple PDs/PIs are permitted on an application, which is often important in neural prosthetics where successful translation may require tightly integrated engineering, neuroscience, clinical, regulatory, and biostatistics expertise. Applicants may submit more than one application as long as each is scientifically distinct, giving organizations room to propose multiple device concepts or separate translational pathways without forcing them into a single oversized proposal.

In terms of resubmissions and renewals, the FOA allows resubmission applications, but they must include an Introduction that responds to prior peer review critiques (the Summary Statement). It also reflects NIH policy at the time regarding the number of allowed amendments: for applications intended for the January 25, 2009 due date and later, only one amendment (A1) was permitted for original new and competing renewal applications, while older “grandfathered” submissions could have up to two amendments (A1 and A2) under specific timing limits, with NIH not accepting A2 submissions after January 7, 2011. Renewals (competing continuations) are allowed when the new work is a logical progression of an existing NIH U01 project, which is relevant for multi-stage technology development where early clinical feasibility work may lead to an expanded or refined next phase.

Administratively, the opportunity is categorized as discretionary and uses the cooperative agreement funding instrument type, with activity categories tied to health-related research and technology innovation. The CFDA numbers associated with the announcement include 93.286 (technological innovations to improve human health), 93.853 (neurosciences and neurological disorders extramural research), and 93.865 (child health and human development extramural research). There is no cost sharing or matching requirement. The FOA was posted December 22, 2008, and the record includes key dates such as an original closing date of January 7, 2012, a current closing date listed as March 14, 2011, and an archive date of April 14, 2011, reflecting that it is now an archived opportunity rather than an open solicitation. For full details, NIH referenced the official guide notice link at http://grants.nih.gov/grants/guide/pa-files/PA-09-063.html and provided the NIH Office of Extramural Research (OER) webmaster contact for access or linking issues.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health Income Security and Social Services

Next opportunity: Office of Safe and Drug Free Schools Overview Information Partnerships in Character Education Program CFDA 84.215S

Previous opportunity: CLEAN VESSEL GRANT PROGRAM

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 09 063

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 09 063) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 09 063", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.